Bausch Health Companies (TSE:BHC) Posts Earnings Results

Bausch Health Companies (TSE:BHC) announced its quarterly earnings results on Wednesday. The company reported C($0.41) earnings per share for the quarter, FiscalAI reports. The firm had revenue of C$6.62 billion for the quarter. Bausch Health Companies had a negative net margin of 1.88% and a positive return on equity of 15.87%.

Bausch Health Companies Stock Up 4.2%

Bausch Health Companies stock opened at C$8.51 on Thursday. Bausch Health Companies has a one year low of C$5.91 and a one year high of C$11.97. The stock has a fifty day moving average of C$9.14 and a 200 day moving average of C$9.26. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19. The stock has a market cap of C$3.15 billion, a PE ratio of 8.77, a price-to-earnings-growth ratio of 0.21 and a beta of 0.10.

Analyst Ratings Changes

A number of research firms have commented on BHC. Raymond James Financial raised Bausch Health Companies to a “hold” rating in a report on Monday, December 15th. Barclays upgraded Bausch Health Companies to a “hold” rating in a report on Monday, December 8th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

About Bausch Health Companies

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.